Dynamic42 interviewed by MDR
In the interview with MDR Thüringen, we answer many questions about our company, our vision and we reveal how we came up with the name “Dynamic42”. You can find the complete interview and the feature in the MDR Thüringen Journal here.
Read more News:
News
Cancer, rheumatism, asthma: organ-on-chip models highly relevant for preclinical testing of therapeutic antibodies
Improving people's lives with innovative technologies. This was the goal that Jena-based Dynamic42 had in mind 18 months ago when they launched a project - funded as part of the Sanofi iDEA-iTECH Award Program.
Read MoreNews
ATHANA alliance for antifungal therapy approaches – First strategy workshop
The RUBIN alliance “ATHANA” met for their first strategy workshop one year after the project kicked off in summer last year.
Read MoreNews
Amélie Marie Paillereau joins Dynamic42 as Master Student funded by the Thuringia and European Social Fund Plus
We are excited to welcome Amélie Marie Paillereau to the Dynamic42 science team. Amélie started in April with us for a 12-month-long Master thesis, focusing on perfused breast and pancreatic cancer-on-chip models to study the impact of the tumor microenvironment on immune cell invasion.
Read More